The Dodd-Frank Wall Street Reform and
Consumer Protection Act (Dodd-Frank Act) was enacted on July 21,
2010. Section 619 of the Dodd-Frank Act, also known as the Volcker
Rule, adds a new section 13 to the Bank Holding Company Act of 1956
(BHC Act) that generally prohibits any banking entity from engaging
in proprietary trading or from investing in, sponsoring, or having
certain relationships with a hedge fund or private equity fund
(together, a covered fund). Section 13 of the BHC Act also provides
that nonbank financial companies designated by the Financial
Stability Oversight Council (Council) that engage in proprietary
trading activities or make investments in covered funds may be made
subject by rule to additional capital requirements or quantitative
limits. In December 2013, the Board, Office of the Comptroller of
the Currency (OCC), Federal Deposit Insurance Corporation (FDIC),
Securities and Exchange Commission (SEC), and Commodity Futures
Trading Commission (CFTC) (the agencies) approved final regulations
implementing the provisions of section 13 of the BHC Act (the
“final rule”). The restrictions and prohibitions of section 13 of
the BHC Act became effective on July 21, 2012, however, the statute
provided banking entities a grace period until July 21, 2014, to
conform their activities and investments to the requirements of the
statute and any rule issued by the agencies. The statute also
granted exclusively to the Board authority to provide banking
entities additional time to conform or divest their investments and
activities covered by section 13. The statute provides that the
Board may, by rule or order, extend the conformance period “for not
more than one year at a time,” up to three times, if in the
judgment of the Board, an extension is consistent with the purposes
of section 13 and would not be detrimental to the public interest.
This would allow extensions of the conformance period until July
21, 2017. Section 13 also permits the Board, upon application by a
banking entity, to provide up to an additional five-year transition
period to conform certain illiquid funds. Section 13 also gives
nonbank financial companies supervised by the Board the same
general two-year conformance period with the potential of up to
three, one-year extensions to bring their activities into
compliance with any requirements or limits established. Consistent
with the conformance period available to banking entities, the
Board has the ability to extend this two-year period by up to three
additional one-year periods, if the Board determines that such an
extension is consistent with the purpose of the Volcker Rule and
would not be detrimental to the public interest. In February 2011,
the Board adopted a final rule to implement the conformance period
provisions of section 13 (Conformance Rule) during which banking
entities and nonbank financial companies supervised by the Board
must bring their activities and investments into compliance with
the Volcker Rule and implementing regulations. The information
collections associated with the Conformance Rule are located in
sections 225.181(c) and 225.182(c) of Regulation Y. Sections
225.181(c) and 225.182(c) permit a banking entity and nonbank
financial company, respectively, to request an extension of time to
conform their activities to the Volcker Rule. The Conformance Rule
became effective April 1, 2011.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.